Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hyperfine (HYPR) Other financing activities (2021)

Hyperfine posted quarterly Other financing activities of -$3.5 million for Q4 2021, down 224.61% on a QoQ basis from $2.8 million in Q2 2021.

Hyperfine (HYPR) has 1 years of Other financing activities data on file, last reported at -$3.5 million in Q4 2021.

  • For the quarter ending Q4 2021, Other financing activities changed N/A year-over-year to -$3.5 million; the trailing twelve-month figure through Dec 2021 stood at $7000.0 (changed N/A YoY), and the FY2021 full-year result was $7000.0, down 99.3% from the prior year.
  • Other financing activities for Q4 2021 stood at -$3.5 million, down from $2.8 million in the prior quarter.
  • Across five years, Other financing activities topped out at $2.8 million in Q2 2021 and bottomed at -$3.5 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Hyperfine 149.47 Mn 108.20 Mn 1.98 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 -3.51 Mn
Dec 31, 2021 -3.51 Mn
Jun 30, 2021 2.82 Mn
Jun 30, 2021 2.82 Mn
Mar 31, 2021 700,000.00
Mar 31, 2021 700,000.00